{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:33:56Z","timestamp":1767652436298},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kamin","award":["46292"],"award-info":[{"award-number":["46292"]}]}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jocn.2014.11.027","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T20:56:02Z","timestamp":1429131362000},"page":"986-989","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Hanna","family":"Charbit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arriel","family":"Benis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Geyshis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Karussis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayota","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Lavon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.11.027_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mcp.2010.04.006","article-title":"The genetics of multiple sclerosis: an update 2010","volume":"24","author":"Hoffjan","year":"2010","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.jocn.2014.11.027_b0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2014.11.027_b0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/jir.2010.0085","article-title":"Single-nucleotide polymorphisms in response to interferon-beta therapy in multiple sclerosis","volume":"30","author":"Vandenbroeck","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jocn.2014.11.027_b0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nurt.2007.07.001","article-title":"Interferon-beta treatment for multiple sclerosis","volume":"4","author":"Bermel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jocn.2014.11.027_b0025","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.drudis.2008.08.003","article-title":"Modern multiple sclerosis treatment \u2013 what is approved, what is on the horizon","volume":"13","author":"Pilz","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jocn.2014.11.027_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/01.WNL.0000078888.07196.0B","article-title":"Clinical characteristics of responders to interferon therapy for relapsing MS","volume":"61","author":"Waubant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.11.027_b0035","doi-asserted-by":"crossref","first-page":"e1927","DOI":"10.1371\/journal.pone.0001927","article-title":"Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients","volume":"3","author":"van Baarsen","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocn.2014.11.027_b0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/08916930903219040","article-title":"Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis","volume":"43","author":"Serrano-Fernandez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jocn.2014.11.027_b0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1191\/1352458502ms853oa","article-title":"Low interferon gamma producers are better treatment responders: a two-year follow-up of interferon beta-treated multiple sclerosis patients","volume":"8","author":"Petereit","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.11.027_b0050","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/brain\/awg147","article-title":"Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis","volume":"126","author":"Sturzebecher","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.11.027_b0055","doi-asserted-by":"crossref","unstructured":"Kulkarni MM. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr Proctoc Mol Biol 2011; Chapter 25:Unit25B.","DOI":"10.1002\/0471142727.mb25b10s94"},{"key":"10.1016\/j.jocn.2014.11.027_b0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4419-7046-6_33","article-title":"Biomarkers discovery in medical genomics data","volume":"696","author":"Benis","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jocn.2014.11.027_b0065","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2014.11.027_b0070","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2006"},{"key":"10.1016\/j.jocn.2014.11.027_b0075","unstructured":"Warnes G, Bolker B, Lumley T. gplots: various R programming tools for plotting data. R package version 2.6.0."},{"key":"10.1016\/j.jocn.2014.11.027_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jns.2008.07.028","article-title":"Translation towards personalized medicine in multiple sclerosis","volume":"274","author":"Miller","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2014.11.027_b0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ncl.2010.12.009","article-title":"The immunopathophysiology of multiple sclerosis","volume":"29","author":"Wu","year":"2011","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jocn.2014.11.027_b0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jocn.2014.11.027_b0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2010.05.038","article-title":"Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose","volume":"226","author":"Cucci","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2014.11.027_b0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1352458510393263","article-title":"CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment","volume":"17","author":"Alvarez-Lafuente","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.11.027_b0105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/ene.12193","article-title":"Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-beta treatment","volume":"20","author":"Malhotra","year":"2013","journal-title":"Euro J Neurol"},{"key":"10.1016\/j.jocn.2014.11.027_b0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/gene.2011.18","article-title":"Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon beta therapy in multiple sclerosis","volume":"12","author":"Vosslamber","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.jocn.2014.11.027_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneurol.2012.43","article-title":"Sex-related factors in multiple sclerosis susceptibility and progression","volume":"8","author":"Voskuhl","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2014.11.027_b0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1352458508099479","article-title":"Gender-related differences in MS: a study of conventional and nonconventional MRI measures","volume":"15","author":"Antulov","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.11.027_b0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jocn.2014.11.027_b0130","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","article-title":"The role of gender and organ specific autoimmunity","volume":"11","author":"Nussinovitch","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2014.11.027_b0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(97)05396-3","article-title":"Menstrually related worsening of symptoms in multiple sclerosis","volume":"149","author":"Zorgdrager","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2014.11.027_b0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.53.3.622","article-title":"MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns","volume":"53","author":"Pozzilli","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.11.027_b0145","doi-asserted-by":"crossref","first-page":"A486","DOI":"10.1016\/j.autrev.2011.11.023","article-title":"Immunology and the menstrual cycle","volume":"11","author":"Oertelt-Prigione","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2014.11.027_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1479-5876-10-223","article-title":"A gender-related action of IFNbeta-therapy was found in multiple sclerosis","volume":"10","author":"Contasta","year":"2012","journal-title":"J Transl Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T09:26:36Z","timestamp":1537694796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586815000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0967586815000272"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.11.027","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}